| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Regenxbio Inc. (RGNX) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 23 sells. RGNX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 495.9K | $5.52M | - | |
| CEO | 338.1K | $3.76M | - | |
| Other | 215.4K | $2.40M | - | |
| Other | 64.8K | $721.0K | - | |
| CFO | 39.6K | $441.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 25, 2021 | Mills Kenneth T.81 | President And CEO | Sale+OE | 6,500 | $44.74 | $290,779.19 | -0.8% | |
| Jan 15, 2021 | Vasista Vittal79 | Chief Financial Officer | Sell | 252 | $50.04 | $12,610.08 | -0.2% | |
| Jan 14, 2021 | Simpson Curran66 | Chief Oper. &Tech. Officer | Sale+OE | 13,312 | $50.01 | $665,767.12 | -27.3% | |
| Jan 14, 2021 | Vasista Vittal79 | Chief Financial Officer | Sell | 15,293 | $50.02 | $765,024.79 | -6.0% | |
| Jan 12, 2021 | Christmas Patrick J. | Chief Legal Officer | Sale+OE | 21,500 | $48.14 | $1,035,081.84 | -19.5% | |
| Jan 8, 2021 | Vasista Vittal79 | Chief Financial Officer | Sell | 16,239 | $49.06 | $796,614.87 | -3.0% | |
| Jan 7, 2021 | Simpson Curran66 | Chief Oper. &Tech. Officer | Sale+OE | 5,185 | $50.01 | $259,301.85 | -22.6% | |
| Jan 7, 2021 | Mills Kenneth T.81 | President And CEO | Sale+OE | 1,500 | $50.01 | $75,015.00 | -0.5% | |
| Dec 28, 2020 | Mills Kenneth T.81 | President And CEO | Sale+OE | 6,500 | $48.67 | $316,333.57 | -1.3% | |
| Dec 24, 2020 | Vasista Vittal79 | Chief Financial Officer | Sell | 24,500 | $50.01 | $1,225,211.24 | -8.3% |